1Withage MI, Wallenburg HC, Steegers EA, et al. Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsia [J]. BJOG,2005,112(7):910-914.
7Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of reeclampsia [J]. N Engl J Med,2004,350(11):672-683.
8Hertig A, Berkane N, Lefevre G, et al. Maternal serum sFh-1 concentration is an early and reliable predictive marker of preeclampsia [J]. Clinical Chemistry,2004,50(7): 1702-1703.
9Fayyad AM, Harrington KF. Prediction and prevention of preeclampsia and IUGR [J]. Early Hum Dev,2005,81(6):865-876.
8Kadyrov M, Kaufrnann P, Huppertz B. Expression of a cytokeratin 18 neoepitope is a specific marker for trophoblast apoptosis in human placenta [J ] . Placenta,2001,22(1) :44-48
9Aly AS, Khandelwal M, Zhao J, et al. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia [J ] . Am J Obstet Gynecol, 2004, 190( 1 ) : 252 - 258
10Huppertz B, Kingdom J, Caniggia L, et al. Hypoxia favours necrotic versus apoptotic shedding of placenta syncytiotrophoblast into the maternal circulation[J].Placenta,2003 ,24(2 - 3) : 181 - 190
